Crossmark

Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era

Crossref DOI link: https://doi.org/10.1186/s40164-022-00265-2

Published Online: 2022-03-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shi, Ting

Xie, Mixue

Chen, Li

Yuan, Wei

Wang, Yungui

Huang, Xin

Xie, Wanzhuo

Meng, Haitao

Lou, Yinjun

Yu, Wenjuan

Tong, Hongyan

Ye, Xiujin

Huang, Jinyan

Jin, Jie

Zhu, Honghu
License Information

Text and Data Mining valid from 2022-03-11

Version of Record valid from 2022-03-11
More Information

Article History

Received: 11 November 2021

Accepted: 16 February 2022

First Online: 11 March 2022

Declarations

:

: This study was approved by the Institutional Review Board of the First Affiliated Hospital, Zhejiang University School of Medicine.

: Written informed consent was obtained from the participants’ legal guardians.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below